Results 161 to 170 of about 118,013 (268)

Therapeutic Implications of ErbB Pathway Modification in Heart Failure with Reduced Ejection Fraction. [PDF]

JACC Basic Transl Sci
Selvaraj S, Felker GM.
europepmc   +1 more source

Comparative Analysis of Intravascular Lithotripsy With and Without Atherectomy in Severely Calcified Coronary Lesions Using OCT and OFDI

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Intravascular lithotripsy (IVL) fractures calcified plaques and facilitates lesion expansion; however, unlike atherectomy devices, it does not reduce calcium volume. The therapeutic efficacy and safety of combining IVL with atherectomy remain unclear. Therefore, this study aimed to evaluate, through optical coherence tomography (OCT)
Marohito Nakata, Masami Abe, Toshiya Chinen, Kentaro Nakamura   +3 more
wiley   +1 more source

Physician adherence to heart failure with reduced ejection fraction treatment guidelines: a cross-sectional study in Northwest Ethiopia. [PDF]

BMC Cardiovasc Disord
Workineh TF, Alem DT, Iyassu AS, Hunegnaw W, Tiruneh BG, Anagaw TF.   +5 more
europepmc   +1 more source

Interleukin (IL)‐5, Eosinophils and IL‐5 Pathway Inhibitors in Eosinophilic Granulomatosis with Polyangiitis.

Arthritis &Rheumatology, Accepted Article.
Alvise Berti, Christian Pagnoux
wiley   +1 more source

Applying DanGer Shock Eligibility Criteria to a Real‐World Cohort of Cardiogenic Shock Patients

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The DanGer Shock trial investigated the effects of adding a microaxial flow pump to guideline‐recommended therapy in patients with ST‐elevation myocardial infarction (STEMI)‐related cardiogenic shock (CS), finding a lower all‐cause mortality at 180 days in the intervention group.
Raffaela Miriam Planka, Lukas Herold, Theresa Glantschnig, Gudrun Sommer, Jonathan Pavek, Stefan Hatzl, Nicolas Verheyen, Christoph Strohhofer, Johannes Gollmer, Ewald Kolesnik, Martin Benedikt, Markus Wallner, Andreas Zirlik, Gabor Toth‐Gayor, Dirk von Lewinski   +14 more
wiley   +1 more source

Meta-analysis of a controlled study of levosimendan combined with Sacubitril/Valsartan for the treatment of heart failure with reduced ejection fraction in China

Li Che, Jifeng Zheng, Bin Zhang, Jianjiang Xu, Zhenliang Chu   +4 more
openalex   +1 more source

Levosimendan in Decompensated Heart Failure with Reduced Ejection Fraction in Older Adults: A Systematic Review of Safety and Efficacy. [PDF]

Medicines (Basel)
Zavaleta-Monestel E, Mora-Jiménez J, Cruz-Mora K, Martinez-Vargas E, Díaz-Madriz JP, Arguedas-Chacón S, Fallas-Mora A, Wu-Chin C, Chaverrí-Fernandez JM.   +8 more
europepmc   +1 more source

Left Ventricular Apical Thrombus in Apical Hypertrophic Cardiomyopathy Without Aneurysm or Arrhythmia: A Case Report

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Apical hypertrophic cardiomyopathy (ApHCM) is a rare variant of hypertrophic cardiomyopathy, typically associated with a benign course. However, complications such as ventricular arrhythmias, apical aneurysms, and thrombus formation may occur. Left ventricular (LV) thrombus is an unusual finding in ApHCM, especially in patients with preserved ...
Ibrahim Antoun, Jeffrey Khoo, Sanjay S. Bhandari   +2 more
wiley   +1 more source

Impact of centrifugal-flow left ventricular assist device implantation on the disease course, functional class, and quality of life in patients with end-stage heart failure with reduced ejection fraction. A 6-month follow-up experience

Janna A. Shahramanova, O. Yu. Narusov, V. A. Amanatova, Yu. F. Osmolovskaya, K. G. Ganaev, A.A. Shiryaev, Р.С. Акчурин, И. Б. Меркулова, Д. В. Певзнер, М. А. Саидова, С. Н. Терещенко   +10 more
openalex   +1 more source

Heart Failure With Reduced Ejection Fraction And A Narrow QRS Complex: Combination Of A Subcutaneous Defibrillator With Cardiac Contractility Modulation.

, 2015
Susanne Röger, Martin Borggrefe, Jürgen Kuschyk   +2 more
openalex   +1 more source